JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB252895

Fatty Acid Amide Hydrolase Activity Assay Kit (Fluorometric)

4

(1 리뷰)

|

(3 제품이 사용된 논문 )

In Fatty Acid Amide Hydrolase Activity Assay Kit (Fluorometric) (ab252895), FAAH hydrolyzes a non-fluorescent substrate releasing 7-amino-4-methylcoumarin (AMC), a fluorophore, which can be easily measured at Ex/Em= 360/465 nm.

대체 명칭 보기

FAAH1, FAAH, Fatty-acid amide hydrolase 1, Anandamide amidohydrolase 1, Fatty acid ester hydrolase, Oleamide hydrolase 1

3 이미지
Functional Studies - Fatty Acid Amide Hydrolase Activity Assay Kit (Fluorometric) (AB252895)
  • FuncS

Supplier Data

Functional Studies - Fatty Acid Amide Hydrolase Activity Assay Kit (Fluorometric) (AB252895)

Kinetic measurement of FAAH activity.

Lysates prepared from blank (no sample), rat liver microsome (RLM : 32 μg) and rat liver lysate (RLL : 80 μg) and FAAH Positive Control.

Functional Studies - Fatty Acid Amide Hydrolase Activity Assay Kit (Fluorometric) (AB252895)
  • FuncS

Supplier Data

Functional Studies - Fatty Acid Amide Hydrolase Activity Assay Kit (Fluorometric) (AB252895)

AMC standard curve.

Functional Studies - Fatty Acid Amide Hydrolase Activity Assay Kit (Fluorometric) (AB252895)
  • FuncS

Supplier Data

Functional Studies - Fatty Acid Amide Hydrolase Activity Assay Kit (Fluorometric) (AB252895)

FAAH specific activity.

Activity of two rat liver microsome preparations (RLM1 and RLM2) and rat liver lysate (RLL : 80 μg).

주요 정보

검출 방식

Fluorescent

샘플 타입

Suspension cells, Microsomes, Tissue Homogenate, Adherent cells

Sensitivity

= 0.1 µU

분석 플랫폼

Microplate

style
left-column

보완 제품

Assay Kits

AB65336

Triglyceride Assay Kit - Quantification

Biochemical assay - Triglyceride Assay Kit - Quantification (AB65336)

  • 4
  • 5
Primary Antibodies

AB54615

Anti-FAAH1 antibody [4H8]

Western blot - Anti-FAAH1 antibody [4H8] (AB54615)

  • 5
  • 6
Assay Kits

AB65341

Free Fatty Acid Assay Kit - Quantification

Biochemical assay - Free Fatty Acid Assay Kit - Quantification (AB65341)

  • 5
  • 1
Assay Kits

AB65390

Cholesterol Assay Kit - HDL and LDL/VLDL

Biochemical assay - Cholesterol Assay Kit - HDL and LDL/VLDL (AB65390)

  • 4
  • 10
style
left-column

Reactivity 정보

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "Enzyme activity assay": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }
style
left-column

제품 세부 정보

In Fatty Acid Amide Hydrolase Activity Assay Kit (Fluorometric) (ab252895), FAAH hydrolyzes a non-fluorescent substrate releasing 7-amino-4-methylcoumarin (AMC), a fluorophore, which can be easily measured at Ex/Em= 360/465 nm. The kit provides a specific inhibitor that can be used to compensate for potential non-specfic background in unknown samples. The stable fluorescence signal is positively correlated to FAAH enzymatic activity in samples. The kit offers a rapid, simple, sensitive, reproducible assay and is suitable for detecting FAAH activity as low as 0.1 μU.

This product is manufactured by BioVision, an Abcam company and was previously called K434 Fatty Acid Amide Hydrolase (FAAH) Activity Assay Kit (Fluorometric). K434-100 is the same size as the 100 test size of ab252895.

style
left-column

제품 구성

{ "values": { "100Test": { "sellingSize": "100 Test", "publicAssetCode":"ab252895-100Test", "assetComponentDetails": [ { "size":"1 x 25 mL", "name":"Assay Buffer 59", "number":"AB252895-CMP02", "productcode":"" }, { "size":"1 x 100 µL", "name":"AMC Standard", "number":"AB252895-CMP01", "productcode":"" }, { "size":"1 x 100 µL", "name":"FAAH Substrate", "number":"AB252895-CMP05", "productcode":"" }, { "size":"1 x 100 µL", "name":"FAAH Inhibitor", "number":"AB252895-CMP03", "productcode":"" }, { "size":"1 x 40 µL", "name":"FAAH Positive Control", "number":"AB252895-CMP04", "productcode":"" } ] } } }
style
left-column

특성 및 보관 정보

배송 시 보관 조건
Blue Ice
적절한 단기 보관 조건
-20°C
적절한 장기 보관 조건
-20°C
보관 정보
-20°C
style
left-column

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

Fatty acid amide hydrolase 1 (FAAH1) often referred to simply as FAAH is an enzyme that plays a critical role in the degradation of fatty acid amides such as anandamide in the body. This enzyme weighing approximately 63 kDa is a part of the amidase signature family and is characterized by its amidase hydrolase activity. FAAH1 is predominantly expressed in the nervous system liver and gastrointestinal tract where it hydrolyses amide bonds facilitating the termination of signaling pathways initiated by neurotransmitter-like fatty acid amides.
Biological function summary

FAAH1 is essential for maintaining homeostasis by modulating levels of bioactive lipids. It exerts control over endocannabinoid signaling by breaking down anandamide a lipid derivative functioning as a neurotransmitter. FAAH1 does not act as part of a larger protein complex. Instead it operates alone to regulate the duration and intensity of signaling rather than relying on direct interactions within a complex. The enzyme's function impacts the neurochemical milieu in tissues where it is actively expressed thereby affecting mood pain sensation and more.

Pathways

FAAH1 has a significant role in the endocannabinoid signaling pathway and fatty acid metabolism. Within these pathways it modulates signaling by hydrolysing bioactive amides like anandamide influencing overall lipid signaling. FAAH1 activities intersect with several other proteins such as cannabinoid receptors which bind the substrates that FAAH1 eventually degrades. These interactions are vital in controlling signal transduction processes that regulate physiological responses including stress and analgesia.

FAAH1 has been implicated in conditions like chronic pain and anxiety disorders. Altered FAAH1 function or expression can lead to dysregulation of endocannabinoid signaling contributing to the pathophysiology of these conditions. The enzyme's modulation of anandamide levels connects it to proteins such as CB1 and CB2 cannabinoid receptors which mediate the effects of endocannabinoids in neurological and psychiatric disorders. Research into FAAH1 inhibitors as therapeutic agents highlights its importance in potential treatments for managing pain and anxiety.
style
left-column

제품 프로토콜

style
left-column

타겟 정보

Catalyzes the hydrolysis of endogenous amidated lipids like the sleep-inducing lipid oleamide ((9Z)-octadecenamide), the endocannabinoid anandamide (N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine), as well as other fatty amides, to their corresponding fatty acids, thereby regulating the signaling functions of these molecules (PubMed : 17015445, PubMed : 19926788, PubMed : 9122178). Hydrolyzes polyunsaturated substrate anandamide preferentially as compared to monounsaturated substrates (PubMed : 17015445, PubMed : 9122178). It can also catalyze the hydrolysis of the endocannabinoid 2-arachidonoylglycerol (2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glycerol) (PubMed : 21049984). FAAH cooperates with PM20D1 in the hydrolysis of amino acid-conjugated fatty acids such as N-fatty acyl glycine and N-fatty acyl-L-serine, thereby acting as a physiological regulator of specific subsets of intracellular, but not of extracellular, N-fatty acyl amino acids (By similarity).
See full target information FAAH
style
left-column

제품이 사용된 논문 (3)

Recent publications for all applications. Explore the 전체 목록 and refine your search

Cells 12: PubMed36611887

2022

Kidney Proximal Tubule GLUT2-More than Meets the Eye.

Applications

Unspecified application

Species

Unspecified reactive species

Majdoleen Ahmad,Ifat Abramovich,Bella Agranovich,Alina Nemirovski,Eyal Gottlieb,Liad Hinden,Joseph Tam

Nature communications 13:6941 PubMed36396957

2022

The endocannabinoid anandamide is an airway relaxant in health and disease.

Applications

Unspecified application

Species

Unspecified reactive species

Annika Simon,Thomas von Einem,Alexander Seidinger,Michaela Matthey,Laura Bindila,Daniela Wenzel

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 48:897-907 PubMed36114286

2022

Anandamide and 2-arachidonoylglycerol differentially modulate autistic-like traits in a genetic model of autism based on FMR1 deletion in rats.

Applications

Unspecified application

Species

Unspecified reactive species

Sara Schiavi,Antonia Manduca,Emilia Carbone,Valeria Buzzelli,Alessandro Rava,Alessandro Feo,Fabrizio Ascone,Maria Morena,Patrizia Campolongo,Matthew N Hill,Viviana Trezza
제품이 사용된 논문 모두 보기
style
left-column
style
left-column
websiteProtocolBooklet
en
style
right-column

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com